SEN-1186

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSEN-1186
Drug Alias Nameaggregation inhibitor (Senexis)SEN-1186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSenexis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSenexis Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A